BMC Infectious Diseases, 11 (1), P. 248.: Daftar Pustaka

ANALISIS FARMAKOEKONOMI VAKSINASI PNEUMOCOCCAL CONJUGATE VACCINE (PCV) 10 DAN
13 PADA INVASIVE
DISEASES ANAK DI DAERAH ISTIMEWA YOGYAKARTA
INGENIDA HADNING, apt. Tri Murti Andayani, Sp.FRS., Ph.D.; apt. Dwi Endarti, M.Sc., Ph.D.; dr. Rina Triasih, M.Me
Universitas Gadjah Mada, 2021 | Diunduh dari http://etd.repository.ugm.ac.id/
DAFTAR PUSTAKA
Alam, A., 2016. Kejadian Meningitis Bakterial pada Anak usia 6-18 bulan yang
Menderita Kejang Demam Pertama. Sari Pediatri, 13(4), pp. 293-8.
Aljunid, S. dkk., 2011. Impact of routine PCV 7 (Prevenar) vaccination of infants
on the clinical and economic burden of pneumococcal disease in Malaysia.
BMC Infectious Diseases, 11(1), p. 248.
Aminullah, A., Hadisaputro, S., Soemantri, A. & Suhartono, S., 2016. Kadar
Oksidan yang Tinggi Sebagai Faktor Risiko Terjadinya Hemolisis pada
Neonatus Sepsis. Sari Pediatri, 14(3), pp. 198-204.
Andayani, T. M., 2013. Farmakoekonomi prinsip dan metodologi. Yogyakarta:
Bursa Ilmu.
Anh, D. D. dkk., 2010. Treatment Costs of Pneumonia, Meningitis, Sepsis, and
Other Diseases among Hospitalized Children in Viet Nam. Journal of
Health, Population and Nutrition, 28(5), pp. 436-442.
Ardianti , S., Budiono, U. & Ciptaningtyas, R., 2013. Pola Kuman Pada Pasien
Sepsis yang Dirawat di ICU RSUP Dr. Kariadi Semarang: Periode 1
Januari–31 Desember 2011. Semarang: Doctoral dissertation, Faculty of
Medicine University Diponegoro.
Aspesberro, F., Mangione-Smith, R. & Zimmerman, J. J., 2015. Health-related
quality of life following pediatric critical illness. Intensive Care Medicine,
41(7), pp. 1235-1246.
Atti, M. C. d. dkk., 2014. In-hospital management of children with bacterial
meningitis in Italy. Italian Journal of Pediatrics, 40(1), pp. 1-7.
Black, S. dkk., 2000. Efficacy, safety and immunogenicity of heptavalent
pneumococcal conjugate vaccine in children. The Pediatric Infectious
Disease Journal, 19(3), pp. 187-195.
Black, S. dkk., 2002. Effectiveness of heptavalent pneumococcal conjugate
vaccine in children younger than five years of age for prevention of
pneumonia. The Pediatric Infectious Disease Journal, 21(9), pp. 810-815.
Bluestone, C. D. & Klein, J. O., 2007. Otitis media in infants and children. USA:
PMPH.
Bluestone, C. D., Stephenson, J. S. & Martin, L. M., 1992. Ten-year review of
otitis media pathogens. The Pediatric Infectious Disease Journal, 11(8),
pp. S7-11.
Bootman, J. L., Towsend, R. J. & McGhan, W. F., 2005. Principles of
Pharmacoeconomics. 3rd ed. USA: Harvey Whitney Books Company.
Badan Pusat Statistik DIY, 2020. Upah Minimum Provinsi di DI Yogyakarta
(rupiah) 2018-2020. yogyakarta.bps.go.id. [Online]. Available at:
https://yogyakarta.bps.go.id/indicator/6/272/1/upah-minimum-kabupaten-
upah-minimum-provinsi-di-di-yogyakarta.html. [Diunduh 23 Januari
2020].
Badan Pusat Statistik, 2020. GDP Indonesia Tahun 2019, Jakarta: Badan Pusat
Statistik.
Briggs, A., Sculpher, M. & Karl, C., 2006. Decision Modeling for Health
Economic Evaluation. Oup Oxford.
140
13 PADA INVASIVE
Brouwer, M. C., Tunkel, A. R. & van de Beek, D., 2010. Epidemiology,

Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis.
Clinical Microbiology Reviews, 23(3), pp. 467-492.
Centers for Disease Control and Prevention (CDC), 2006. Vaccine preventable
deaths and the Global Immunization Vision and Strategy. Morbidity and
Mortality weekly report, 55(18), p. 511.
Centers for Disease Control and Prevention (CDC), 2010. Licensure of a 13-
valent pneumococcal conjugate vaccine (PCV13) and recommendations
for use among children-Advisory Committee on Immunization Practices
(ACIP), 2010. MMWR. Morbidity and mortality weekly report, 59(9), pp.
258-261.
Chaudhuri, A. dkk., 2008. EFNS guideline on the management of
community‐acquired bacterial meningitis: report of an EFNS Task Force
on acute bacterial meningitis in older children and adults. European
Journal of Neurology, 15(7), pp. 649-659.
Che, D., Zhou, H., He, J. & Wu, B., 2014. Modeling the impact of the 7-valent
pneumococcal conjugate vaccine in Chinese infants: an economic analysis
of a compulsory vaccination. BMC health services research, 14(1), pp. 1-
14.
Chen, K. & Pohan, H. T., 2000. Ilmu Penyakit Dalam. 3rd ed. Jakarta: FKUI.
Chuck, A. W., Jacobs, P., Tyrrell, G. & Kellner, J. D., 2010. Pharmacoeconomic
evaluation of 10- and 13-valent pneumococcal conjugate vaccines.
Vaccine, 28(33), pp. 5485-5490.
Claeson, M., Gillespie, D., Mshinda , H. & Troedsson, H., 2003. Bellagio Study
Group on Child Survival: Knowledge into action for child survival. The
Lancet, 362(9380), pp. 323-327.
Constenla, D. dkk., 2007. The burden of pneumococcal disease and cost-
effectiveness of a pneumococcal vaccine in Latin America and the
Caribbean. Sabin Vaccine Institute, Volume 1, p. 129.
Cutts, F. dkk., 2005. Efficacy of nine-valent pneumococcal conjugate vaccine
against pneumonia and invasive pneumococcal disease in The Gambia:
randomised, double-blind, placebo-controlled trial. The Lancet, 365(9465),
pp. 1139-1146.
Destarac, L. A. & Ely, E. W., 2001. Sepsis in Older Patients : An Emerging
Concern in Critical Care. Advances in sepsis, 2(1), pp. 15-22.
Devlin, N. J. & Krabbe, P. F., 2013. The Development of New Research Methods
for The Valuation of EQ-5D-5L. s.l.:s.n.
Dinas Kesehatan, D., 2017. Profil Kesehatan Provinsi DI Yogyakarta Tahun
2017. Yogyakarta: Dinas Kesehatan DIY.
Drummond, M. dkk., 2009. Transferability of economic evaluations across
jurisdictions: ISPOR Good Research Practices Task Force report. Value in
Health, 12(4), pp. 409-418.
Drummond, M. F. dkk., 2015. Methods for the economic evaluation of health care
programmes. Inggris: Oxford university press.
141
13 PADA INVASIVE
Earnshaw, S. R. dkk., 2012. Cost-effectiveness of 2+ 1 dosing of 13-valent and

10-valent pneumococcal conjugate vaccines in Canada. BMC infectious
diseases, 12(1), pp. 1-13.
European Medicines Agency (EMA), 2009. European Medicines Agency.
[Online] Available at: www.ema.europa.eu.
Esposito, S. dkk., 2002. Characteristics of Streptococcus pneumoniae and
Atypical Bacterial Infections in Children 2–5 Years of Age with
Community-Acquired Pneumonia. Clinical Infectious Diseases, 35(11),
pp. 1345-1352.
Faridah, N., Machlaurin, A. & Subagio, P. B., 2016. Analisis Efektivitas Biaya
Penggunaan Antibiotik terhadap Pasien Sepsis Pediatrik di Rawat Inap
RSD dr. Soebandi Kabupaten Jember pada Tahun 2014 (Cost effectiveness
Analysis of Antibiotics in Hospitelized Pediatric Sepsis Patients at RSD dr.
Soebandi Je). Pustaka Kesehatan, 4(2), pp. 255-262.
Farida, H. dkk., 2014. Nasopharyngeal Carriage of Streptococcus pneumonia in
Pneumonia-Prone Age Groups in Semarang, Java Island, Indonesia. PloS
one, 9(1), p. 87431.
Floyd, J. dkk., 2015. Evaluating the impact of pulse oximetry on childhood
pneumonia mortality in resource-poor settings. Nature, 528(7580), pp.
S53-S59.
Flynn, C. A., Griffin, G. & Tudiver, F., 2002. Decongestants and antihistamines
for acute otitis media in children. Cochrane Library, 1.
Ginsberg, L., 2004. Difficult and recurrent meningitis. Journal of Neurology,
Neurosurgery & Psychiatry, 75(1), pp. i16-i21.
Grijalva, C. G. dkk., 2007. Decline in pneumonia admissions after routine
childhood immunisation with pneumococcal conjugate vaccine in the
USA: a time-series analysis. The Lancet, 396(9568), pp. 1179-1186.
Haasis, M. A. dkk., 2015. o Pneumococcal Conjugate Vaccines Represent Good
Value for Money in a Lower-Middle Income Country? A Cost-Utility
Analysis in the Philippines. PLoS one, 10(7), p. e0131156.
Hadning, I., Ikawati, Z. & Andayani, T. M., 2015. Stroke Treatment Cost
Analysis for Consideration on Health Cost Determination Using INA-
CBGs. International Journal of Public Health Science, 4(4), pp. 288-293.
Hamer, D. dkk., 2015. Etiology of Bacteremia in Young Infants in Six Countries.
The Pediatric Infectious Disease Journal, 34(1), pp. 1-8.
Hansen, J. dkk., 2006. Effectiveness of Heptavalent Pneumococcal Conjugate
Vaccine in Children Younger Than 5 Years of Age for Prevention of
Pneumonia: Updated Analysis Using World Health Organization
Standardized Interpretation of Chest Radiographs. The Pediatric Infectious
Disease Journal, 25(9), pp. 779-781.
Harris, M. dkk., 2011. British Thoracic Society guidelines for the management of
community acquired pneumonia in children: update 2011. Thorax, 66(2),
pp. 1-23.
Hartati, S., 2011. Analisis faktor risiko yang berhubungan dengan kejadian
pneumonia pada anak balita di RSUD Pasar Rebo Jakarta. Jakarta:
Magister Ilmu Keperawatan Universitas Indonesia.
142
13 PADA INVASIVE
Hassanah, N. M., Lestari, H. & Rasma, R., 2016. Analisis Faktor Risiko Jenis
Kelamin Bayi, Bblr, Persalinan Prematur, Ketuban Pecah Dini Dan
Tindakan Persalinan Dengan Kejadian Sepsis Neonatus Di Rumah Sakit
Bahteramas Provinsi Sulawesi Tenggara Tahun 2016. Jurnal Ilmiah
Mahasiswa Kesehatan Masyarakat, 1(3).
Heyderman, R. S. dkk., 2003. Early management of suspected bacterial meningitis
and meningococcal septicaemia in adults. Journal of Infection, 46(2), pp.
75-77.
Hussain, H. dkk., 2008. Economic analysis of childhood pneumonia in Northern
Pakistan. Health Policy and Planning, 23(6), pp. 438-442.
Hu, S. dkk., 2014. Estimating the Cost-Effectiveness of the 7-Valent
Pneumococcal Conjugate Vaccine in Shanghai, China. Value in Health
Regional Issues, 3, pp. 197-204.
Jauneikaite, E., Jefferies, J. M., Hibberd, M. L. & Clarke, S. C., 2012. Prevalence
of Streptococcus pneumoniae serotypes causing invasive and non-invasive
disease in South East Asia: A review. Vaccine, 30(24), pp. 3503-3514.
Kang, C.-I. & Song, J.-H., 2013. Antimicrobial resistance in Asia: current
epidemiology and clinical implications. Infection & chemotherapy, 45(1),
p. 22.
Kementerian Kesehatan, 2016. Peraturan Menteri Kesehatan Republik Indonesia,
Nomor 64 Tahun 2016, tentang Perubahan Atas Peraturan Menteri
Kesehatan Nomor 52 Tahun 2016 tentang Standar Tarif Pelayanan
Kesehatan dalam Penyelenggaraan Program Jaminan Kesehatan. Jakarta:
Kementerian Kesehatan Republik Indonesia.
Kementerian Kesehatan, 2018. Riset Kesehatan Dasar Badan Penelitian &
Pengembangan Kesehatan, Jakarta, Kementerian Kesehatan Republik
Indonesia.
Kementerian Kesehatan, 2020. Indonesia Tegaskan Komitmen Pencegahan
Pneumonia di Forum Internasional. [Online] Available at:
https://www.kemkes.go.id/article/print/20013100002/indonesia-tegaskan-
komitmen-pencegahan-pneumonia-di-forum-internasional.html. [Diunduh
21 Juli 2021].
Kementerian Kesehatan, 2021. Vaksinasi PCV Masuk Program Imunisasi Rutin,
Jatim dan Jabar Jadi Lokasi Pertama Pencanangan. [Online] Available
at: https://www.kemkes.go.id/article/print/20013100002/indonesia-
tegaskan-komitmen-pencegahan-pneumonia-di-forum-internasional.html.
[Diunduh 21 Juli 2021].
Kim, S.-Y., Gene, L. & Sue, J. G., 2010. Economic evaluation of pneumococcal
conjugate vaccination in The Gambia. BMC infectious diseases, 10(1), pp.
1-18.
Klugman, K. P. dkk., 2003. A Trial of a 9-Valent Pneumococcal Conjugate
Vaccine in Children with and Those without HIV Infection. New England
Journal of Medicine, 349(14), pp. 1341-1348.
Kozyrskyj, A. L. dkk., 1998. Treatment of Acute Otitis Media With a Shortened
Course of Antibiotics: A Meta-analysis. JAMA, 279(21), pp. 1736-1742.
143
13 PADA INVASIVE
Kulpeng, W. dkk., 2013a. Cost-utility analysis of 10- and 13-valent pneumococcal

conjugate vaccines: Protection at what price in the Thai context?. Vaccine,
31(26), pp. 2839-2847.
Kulpeng, W. dkk., 2013b. Variation of health-related quality of life assessed by
caregivers and patients affected by severe childhood infections. BMC
Pediatrics, 13(1), p. 122.
Lagos, R. dkk., 2008. Age- and serotype-specific pediatric invasive pneumococcal
disease: insights from systematic surveillance in Santiago, Chile, 1994-
2007. The Journal of Infectious Diseases, 198(12), pp. 1809-1817.
Lee, K. K. C. dkk., 2013. The Health Economic Impact of Universal Infant
Vaccination with the 10-Valent Pneumococcal Nontypeable Haemophilus
influenzae Protein D Conjugate Vaccine as Compared with 13-Valent
Pneumococcal Conjugate Vaccine in Hong Kong. Value in Health
Regional Issues, 2(1), pp. 64-74.
Legood, R. dkk., 2009. Health related quality of life in survivors of pneumococcal
meningitis. Acta Paediatrica, 98(3), pp. 543-547.
Levine, O. S. dkk., 2010. Global status of Haemophilus influenzae type b and
pneumococcal conjugate vaccines: evidence, policies, and introductions.
Current opinion in infectious diseases, 23(3), pp. 236-241.
Lieu, T. A. dkk., 2000. Projected Cost-effectiveness of Pneumococcal Conjugate
Vaccination of Healthy Infants and Young Children. JAMA, 283(11), pp.
1460-1468.
MacKinnon III, G. E., 2011. Understanding Health Outcomes and
Pharmacoeconomics. Burlington: Jones & Bartlett Publishers.
Mokkad, A. H. dkk., 2016. Global burden of diseases, injuries, and risk factors for
young people's health during 1990–2013: a systematic analysis for the
Global Burden of Disease Study 2013. The Lancet, 387(10036), pp. 2383-
2401.
Mulyadi, 2005. Akuntansi Biaya. 5th ed. Yogyakarta: UPP AMP YKPN.
Nathan, J. J. dkk., 2013. Prevalence of macrolide resistance and in vitro activities
of six antimicrobial agents against clinical isolates of Streptococcus
pneumoniae from a multi-center surveillance in Malaysia. Med J
Malaysia, 68(2), pp. 119-124.
Nurjannah, dkk., 2011. Insidens Diare pada Anak dengan Pneumonia, Studi
Retrospektif. Sari Pediatri, 13(3), pp. 169-173.
Oemar, M. & Janssen, B., 2013. EQ-5D-5 L user guide-basic information on how
to use the EQ-5D-5 L instrument. Rotterdam: EuroQol Group.
Paradiso, P. R., 2011. Advances in Pneumococcal Disease Prevention: 13-Valent
Pneumococcal Conjugate Vaccine for Infants and Children. Clinical
Infectious Diseases, 52(10), pp. 1241-1247.
Pavia, M. dkk., 2009. Efficacy of Pneumococcal Vaccination in Children Younger
Than 24 Months: A Meta-Analysis. Pediatrics, 123(6), pp. e1103-e1110.
Principi, N. & Esposito, S., 2016. Prevention of Community-Acquired Pneumonia
with Available Pneumococcal Vaccines. International journal of
molecular sciences, 18(1), p. 30.
144
13 PADA INVASIVE
Purba, F. D. dkk., 2017. The Indonesian EQ-5D-5L Value Set.

PharmacoEconomics, 35(11), pp. 1153-1165.
Rabin, R., Oemar, M. & Oppe, M., 2013. User guide: basic information on how to
use the EQ-5D-3L instrument. Rotterdam: Euroqol Group.
Reeder, C. E., 1995. Overview of Pharmacoeconomics and Pharmaceutical
Outcomes Evaluations. American journal of health-system pharmacy,
ASHP, 330(3), pp. 679-686.
Rozenbaum, M. H. dkk., 2010. Cost effectiveness of pneumococcal vaccination
among Dutch infants: economic analysis of the seven valent
pneumococcal conjugated vaccine and forecast for the 10 valent and 13
valent vaccines. Bmj, 340.
Rudan, I. dkk., 2013. Epidemiology and etiology of childhood pneumonia in
2010: estimates of incidence, severe morbidity, mortality, underlying risk
factors and causative pathogens for 192 countries. Journal of Global
Health, 3(1).
Rumbo, H., Sanguanprasit, B. & Wichaikull, S., 2016. Factors Influencing
Preventive Behaviors of Mothers for Diarrhea in Children Aged 1-5 Years
in Buol District, Indonesia. Sociology Study, 6(12), pp. 745-753.
Sáez-Llorens, X. & McCracken Jr, G. H., 2003. Bacterial meningitis in children.
The Lancet, 361(9375), pp. 2139-2148.
Safari, D. dkk., 2014. Serotype Distribution and Antibiotic Susceptibility of
Streptococcus pneumoniae Strains Carried by Children Infected with
Human Immunodeficiency Virus. PLoS one, 9(10), p. 110526.
Sanchez, L., 2008. Pharmacoeconomic: Principkes, Methods and Aplication in
Pharmacotherapy A Pathophysiologic Approach. 6th ed. New York:
McGraw-Hill Companies Inc.
Sandra, D. W., Arsin, A. A. & Mallongi, A., 2015. The Dynamic Model Approach
in Estimating Rabies in North Toraja Regency. International Journal of
Sciences: Basic and Applied Research (IJSAR), 24(1), pp. 421-429.
Sari, L. P. A. & Harahap, M. S., 2013. Perbedaan Mortalitas Antara Pasien Sepsis
Dan Sepsis Komplikasi Disseminated Intravascular Coagulation (Dic) Di
Icu Rsup Dr. Kariadi. Jurnal Kedokteran Diponegoro, 2(1), p. 138565.
Sectish, T. & Charles, G., 2007. Pneumonia. In: Behrman RE, editor. Nelson's
textbook of pediatrics. 18th ed. New York: WB Saunders.
Setiawan, D., Endarti, D. & Suwantika, A. A., 2017. Farmakoekonomi Modeling.
Purwokerto: UMP Press.
Sevilla, C., 2007. Research Methods. Quezon: Rex Printing Company.
Shoham, Y. dkk., 2005. Community-acquired pneumonia in children: quantifying
the burden on patients and their families including decrease in quality of
life. Pediatrics, 115(5), pp. 1213-1219.
Simatupang, T., 1995. Pemodelan Sistem. 1st ed. Klaten: Nindita.
Sinha, A. dkk., 2007. Cost-effectiveness of pneumococcal conjugate vaccination
in the prevention of child mortality: an international economic analysis.
The Lancet, 369(9559), pp. 389-396.
Sirisuksan, V., Trung, Q. V. & Riewpaiboon, A., 2017. Cost of pneumonia in
children: A systematic review. Mahidol Univ J Pharm, 44(1), pp. 40-49.
145
13 PADA INVASIVE
Soewignjo, S. dkk., 2001. Streptococcus pneumoniae Nasopharyngeal Carriage

Prevalence, Serotype Distribution, and Resistance Patterns among
Children on Lombok Island, Indonesia. Clinical Infectious Diseases,
32(7), pp. 1039-1043.
Sohn, H. S., Suh, D.-C., Jang, E. & Kwon, J.-W., 2010. Economic evaluation of
childhood 7-valent pneumococcal conjugate vaccination in Korea. Journal
of Managed Care Pharmacy, 16(1), pp. 32-45.
Song, J.-H. dkk., 2004a. High Prevalence of Antimicrobial Resistance among
Clinical Streptococcus pneumoniae Isolates in Asia (an ANSORP Study).
Antimicrobial Agents and Chemotherapy, 48(6), pp. 2101-2107.
Song, J.-H. dkk., 2004b. Macrolide resistance and genotypic characterization of
Streptococcus pneumoniae in Asian countries: a study of the Asian
Network for Surveillance of Resistant Pathogens (ANSORP). Journal of
Antimicrobial Chemotherapy, 53(3), pp. 457-463.
Swanson, D., 2015. Meningitis. Pediatr Rev, 36(12), pp. 514-524.
Tam, P.-Y. I., Bernstein, E., Ma, X. & Ferrieri, P., 2015. Blood Culture in
Evaluation of Pediatric Community-Acquired Pneumonia: A Systematic
Review and Meta-analysis. Hospital Pediatrics, 5(6), pp. 324-336.
Tunkel, A. R. dkk., 2004. Practice guidelines for the management of bacterial
meningitis. Clinical Infectious Diseases, 39(9), pp. 1267-1284.
Tyo, K. R. dkk., 2011. Cost-effectiveness of conjugate pneumococcal vaccination
in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent
vaccines. Vaccine, 29(38), pp. 6686-6694.
United Nations, 2015. invima.gov.co. [Online] Available at:
https://www.invima.gov.co/images/pdf/salasespecializadas/Sala_Especiali
zada_de_Medicamentos/acta2011/ACTA_No_12_DE_2011.pdf. [Diunduh
Mei 2012].
United Nations Children's Fund (UNICEF), 2021. Indonesia Menerima 1,6 Juta
Dosis Vaksin Pneumokokus Pertama Melalui Mekanisme Advance Market
Commitment (AMC) Gavi Untuk Melindungi Anak-anak Dari Pneumonia.
[Online] Available at: https://www.unicef.org/indonesia/id/press-
releases/indonesia-menerima-16-juta-dosis-vaksin-pneumokokus-pertama-
melalui-mekanisme. [Diunduh 21 Juli 2021].
Van de Beek, D., Gans, J. d., Tunkel, A. R. & Wijdicks, E. F. M., 2006.
Community-Acquired Bacterial Meningitis in Adults. New England
Journal of Medicine, 354(1), pp. 44-53.
Vidal, A. & Santos, L., 2017. Comorbidities impact on the prognosis of severe
acute community-acquired pneumonia. Porto Biomedical Journal, 2(6),
pp. 265-272.
Vogenberg, F. R., 2001. Introduction to applied pharmacoeconomics. New York:
The McGraw-Hill Companies, Inc.
Walley, T., 2004. Pharmacoeconomics, Philadelphia: Churchill Livingstone
Press.
Wardlaw, T. M., Johansson, E. W. & Hodge, M. J., 2006. Pneumonia the
forgotten killer of children. s.l.:Unicef.
146
13 PADA INVASIVE
Webster, J. dkk., 2011. An evaluation of emerging vaccines for childhood

pneumococcal pneumonia. BMC Public Health, 11(3), pp. 1-14.
World Health Organization (WHO), 2007. Pneumococcal conjugate vaccine for
childhood immunization—WHO position paper. Weekly Epidemiological
Record= Relevé épidémiologique hebdomadaire, 82(12), pp. 93-104.
World Health Organization (WHO), 2014. Principles and Considerations for
Adding a Vaccine to a National Immunization Programme: From Decision
to Implementation and Monitoring. [Online] Available at:
http://www.who.int/immunization/documents. [Accessed 21 Juli 2021].
World Health Organization (WHO), 2015a. World Health Organization. [Online]
Available at: http://www.who.int/gho/countries/idn.pdf?ua=1. [Diunduh 1
Desember 2015].
World Health Organization (WHO), 2015b. World Health Organization. [Online]
Available at: http://www/who.int/mediacentre/factsheets/fs331/en/.
[Diunduh 3 Desember 2015].
Wilson, J. P. & Rascati, K. L., 2001. Pharmacoeconomics. In: P. Malone, M.
Mosdell K, L. Kier K & J. E. Stanovich, eds. Drug Information: A Guide
for Pharmacist, 2nd edition. New York: Publishing Div. United State, pp.
209-229.
147

BMC Infectious Diseases, 11 (1), P. 248.: Daftar Pustaka

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

BMC Infectious Diseases, 11 (1), P. 248.: Daftar Pustaka

Uploaded by

Copyright:

Available Formats

ANALISIS FARMAKOEKONOMI VAKSINASI PNEUMOCOCCAL CONJUGATE VACCINE (PCV) 10 DAN

Brouwer, M. C., Tunkel, A. R. & van de Beek, D., 2010. Epidemiology,

Earnshaw, S. R. dkk., 2012. Cost-effectiveness of 2+ 1 dosing of 13-valent and

Kulpeng, W. dkk., 2013a. Cost-utility analysis of 10- and 13-valent pneumococcal

Purba, F. D. dkk., 2017. The Indonesian EQ-5D-5L Value Set.

Soewignjo, S. dkk., 2001. Streptococcus pneumoniae Nasopharyngeal Carriage

Webster, J. dkk., 2011. An evaluation of emerging vaccines for childhood

You might also like